Amanzada Ahmad, Kopp Waltraut, Spengler Ulrich, Ramadori Giuliano, Mihm Sabine
Department of Gastroenterology and Endocrinology, University Medical Center Goettingen, Goettingen, Germany.
Department of General Internal Medicine, University Hospital Bonn, Bonn, Germany.
PLoS One. 2013 Dec 20;8(12):e84026. doi: 10.1371/journal.pone.0084026. eCollection 2013.
Eradication of hepatitis C virus (HCV) infection, both spontaneous and treatment-induced, is marked by the wildtype allele C of a single nucleotide polymorphism upstream of the IL28B gene, rs12979860. This favorable allele was recently described to be in linkage disequilibrium with the wildtype allele TT of a dinucleotide polymorphism, ss469415590, located within a new protein-coding gene. While the TT allele introduces a frame-shift and disrupts the open reading frame, only the variant allele, ΔG, creates a novel type III interferon (IFN) protein, IFN-λ4/IFNL4. Absence of IFNL4 is thus supposed to favor resolution of HCV infection. As to date IFNL4 mRNA transcription has only been investigated in polyI:C-stimulated primary human hepatocytes and not yet in HCV infection in vivo, this study analyzed IFNL4 mRNA expression in human liver biopsy specimens. Samples were obtained from patients with a broad panel of disorders including no liver disease, liver diseases of non-viral etiology, chronic hepatitis B and chronic hepatitis C. Hepatic IFNL4 transcripts were detectable exclusively in a subgroup of chronic hepatitis C patients (24/45). Their amounts were positively related to liver HCV RNA copy numbers (p = 0.0023, r = 0.56) suggesting that the hepatic viral load influences IFNL4 transcription irrespective of IFNL4 governing genotype. Both, the IFNL4 creating allele ΔG (p<0.0001) and actual IFNL4 transcription (p = 0.0015) were found to be correlated to the activation of IFN stimulatory genes (ISGs). By contrast, IFNL4 ss469415590 genotypes were not found to be related to IFN-λ2/3/IL28 or IFN-λ1/IL29 gene expression. In conclusion, this study is the first report on intrahepatic transcript levels of the recently discovered IFNL4 gene. Data indicate that HCV infection in particular might activate IFNL4 transcription in the liver. It provides a possible explanation as to why hepatitis C patients show ISG stimulation in their livers in the apparent absence of an induction of other IFN subtypes.
丙型肝炎病毒(HCV)感染的清除,无论是自发清除还是治疗诱导清除,都以IL28B基因上游单核苷酸多态性rs12979860的野生型等位基因C为标志。最近发现,这个有利的等位基因与位于一个新的蛋白质编码基因内的二核苷酸多态性ss469415590的野生型等位基因TT处于连锁不平衡状态。虽然TT等位基因会导致移码并破坏开放阅读框,但只有变异等位基因ΔG能产生一种新型的III型干扰素(IFN)蛋白,即IFN-λ4/IFNL4。因此,缺乏IFNL4被认为有利于HCV感染的清除。由于迄今为止,IFNL4 mRNA转录仅在聚肌胞苷酸(polyI:C)刺激的原代人肝细胞中进行了研究,尚未在体内HCV感染中进行研究,本研究分析了人肝活检标本中IFNL4 mRNA的表达。样本取自患有多种疾病的患者,包括无肝脏疾病、非病毒病因的肝脏疾病、慢性乙型肝炎和慢性丙型肝炎。肝内IFNL4转录本仅在一部分慢性丙型肝炎患者(24/45)中可检测到。它们的数量与肝脏HCV RNA拷贝数呈正相关(p = 0.0023,r = 0.56),这表明肝脏病毒载量影响IFNL4转录,而与IFNL4调控基因型无关。发现IFNL4产生等位基因ΔG(p<0.0001)和实际IFNL4转录(p = 0.0015)均与干扰素刺激基因(ISG)的激活相关。相比之下,未发现IFNL4 ss469415590基因型与IFN-λ2/3/IL28或IFN-λ1/IL29基因表达相关。总之,本研究是关于最近发现的IFNL4基因肝内转录水平的首次报告。数据表明,特别是HCV感染可能会激活肝脏中的IFNL4转录。这为丙型肝炎患者在明显未诱导其他IFN亚型的情况下肝脏中出现ISG刺激提供了一种可能的解释。